Article Information
vol. 353 no. 6304
- Received for publication February 4, 2016
- Accepted for publication July 20, 2016
- .
Article Versions
- Previous version (August 4, 2016 - 10:36).
- You are viewing the most recent version of this article.
Author Information
- Elvira Mass1,*,
- Ivan Ballesteros1,*,
- Matthias Farlik2,*,
- Florian Halbritter2,*,
- Patrick Günther3,*,
- Lucile Crozet1,4,
- Christian E. Jacome-Galarza1,
- Kristian Händler3,
- Johanna Klughammer2,
- Yasuhiro Kobayashi5,
- Elisa Gomez-Perdiguero6,†,
- Joachim L. Schultze3,7,
- Marc Beyer3,7,‡,
- Christoph Bock2,8,9,‡,
- Frederic Geissmann1,4,6,‡,§
- 1Immunology Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA.
- 2CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
- 3Genomics and Immunoregulation, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.
- 4Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA.
- 5Institute for Oral Science, Matsumoto Dental University, 1780 Hiro-Oka Gobara Shiojiri, Nagano 390-0781, Japan.
- 6Centre for Molecular and Cellular Biology of Inflammation, King’s College London, London SE1 1UL, UK.
- 7Single Cell Genomics and Epigenomics Unit at the German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.
- 8Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.
- 9Max Planck Institute for Informatics, 66123 Saarbrücken, Germany.
- ↵§Corresponding author. Email: geissmaf{at}mskcc.org